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Toxicityβ-amyloid peptide (Aβ) is a primary protein component of senile plaques in Alzheimer's disease (AD) and
plays an important, but not fully understood role in neurotoxicity. Model peptides with the demonstrated
ability to mimic the structural and toxicity behavior of Aβ could provide a means to evaluate the
contributions to toxicity that are common to self-associating peptides from many disease states. In this work,
we have studied the peptide–membrane interactions of a model β-sheet peptide, P11-2 (CH3CO-Gln-Gln-Arg-
Phe-Gln-Trp-Gln-Phe-Glu-Gln-Gln-NH2), by ﬂuorescence, infrared spectroscopy, and hydrogen–deuterium
exchange. Like Aβ(1–40), the peptide is toxic, and conditions which produce intermediate oligomers show
higher toxicity against cells than either monomeric forms or higher aggregates of the peptide. Further, P11-2
also binds to both zwitterionic (POPC) and negatively charged (POPC:POPG) liposomes, acquires a partial β-
sheet conformation in presence of lipid, and is protected against deuterium exchange in the presence of
lipids. The results show that a simple rationally designed model β-sheet peptide recapitulates many
important features of Aβ peptide structure and function, reinforcing the idea that toxicity arises, at least in
part, from a common mode of action on membranes that is independent of speciﬁc aspects of the amino acid
sequence. Further studies of such well-behaved model peptide systems will facilitate the investigation of the
general principles that govern the molecular interactions of aggregation-prone disease-associated peptides
with cell and/or membrane surfaces.
© 2009 Published by Elsevier B.V.1. Introduction
Biological molecules, particularly proteins and peptides, have the
ability to self-assemble. Self-assembly of proteins and peptides has
been the focus of intense research in recent years, due to its
importance in understanding a variety of human pathologies such as
Alzheimer's disease (AD), prion disorders, and type 2 diabetes [1]. A
characteristic feature of theses diseases is the deposition of a structure
known as amyloid. In the case of AD, the β-amyloid peptide (Aβ),id peptide; POPC, 1-palmitoyl-
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rk.
lsevier B.V.produced by proteolytic processing of an amyloid precursor protein, is
believed to play a role in neurodegeneration. Originally it was
proposed that the ﬁbrillar Aβ amyloid deposits cause the various
symptoms of AD; however growing evidence indicates that the
smaller, soluble forms of Aβ are the primary neurotoxic species [2–5].
The mechanism of Aβ aggregation has been subject of many studies
[6–10]. Increasing evidence indicates that the neuronal cell membrane
participates in the mechanism of Aβ aggregation. Aβ has been shown
to interact with phospholipid liposomes and the interaction appears
to be aggregation dependent [11], with membrane charge and
composition being important [12–19].
Recent studies suggest that multiple self-associating peptides and
proteins can exhibit toxicity patterns similar to Aβ. The fact that
oligomeric intermediates from multiple misfolding diseases increase
membrane permeability [20] and exhibit toxicity that can be inhibited
by a single anti-oligomer antibody [21] suggests there is at least in part
a common mode of toxicity that is independent of speciﬁc aspects of
sequence. Hence, while it is important to investigate interactions with
membranes that are speciﬁc to Aβ, it is also critical to unearth the
features of peptide–membrane interactions which are common to all
such protein misfolding diseases.
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peptides as novel biomolecular materials that self-assemble in a
hierarchical manner producing an array of structures including ﬁbers,
scaffolds, and lipid-like peptides [22–26]. A set of designed, self-
assembling peptides relevant to amyloid disease is that developed by
Boden et al. [27]. They exploited the biological β-sheet motif to
design simple de novo peptides that self-assemble in a hierarchical
manner to form a variety of well deﬁned nanostructures ranging
from simple monomers to more complex oligomers to supramole-
cular ﬁbrils and ﬁbers. A thorough knowledge of their physico-
chemical behavior in aqueous solution has been achieved and
different states of self-assembly can be controlled and modulated
by changes in concentration, pH, ionic strength and composition
[27,28]. These peptides adopt extended β-strand conformations in
solution, and the β-strands self-assemble in one dimension to form
elongated tapes as well as higher order aggregates with pure
antiparallel β-sheet structure.
In this work, we have characterized the peptide–membrane
interactions of the model self-assembling peptide P11-2 (CH3CO-Gln-
Gln-Arg-Phe-Gln-Trp-Gln-Phe-Glu-Gln-Gln-NH2) by ﬂuorescence and
deuterium exchange techniques. These structural measurements and
corresponding toxicity trends have been compared with those
obtained for Aβ(1–40). The results show that by employing a simple
rationally designedmodel β-sheet peptide it is possible to recapitulate
several features of the Aβ peptide structure and function, reinforcing
the idea that there is a common mode of action and toxicity that is
independent of speciﬁc aspects of the amino acid sequence. Since Aβ
peptides are prone to uncontrolled aggregation in solution and
therefore much more difﬁcult to handle experimentally than P11-2,
the P11-2 model peptide promises to be very useful to uncover many of
the principles that govern the molecular interactions and conforma-
tion changes in the presence of membrane surfaces. At same time, the
controlled self-assembly of P11-2 on membrane surfaces may open
new routes to novel nanostructured materials with a wide range of
applications in biomedicine and nanotechnology.
2. Materials and methods
2.1. Peptides, lipids and chemical compounds
P11-2 (CH3CO-Gln-Gln-Arg-Phe-Gln-Trp-Gln-Phe-Glu-Gln-Gln-
NH2) was synthesized and its purity was conﬁrmed by analytical
high-performance liquid chromatography and mass spectrometry by
the Biomolecular Research Facility at the University of Virginia. P11-2
solutions in 5 mM PBC buffer, pH 7.4 were prepared by dilution of a
stock solution of known concentration. Small aliquots of stock
solutions were frozen immediately after preparation and stored
protected from light at −20 °C. Thawed stock solutions were used
on the same day and never refrozen. Native and ﬂuorescent (labeled
with AMCA [6-((7-amino-4-methylcoumarin-3-acetyl)amino) hexa-
noic acid]) Aβ(1-40) peptides were purchased fromAnaspec, Inc. (San
Jose, CA). Aβ samples were prepared as described before [29]. Brieﬂy,
Aβ was dissolved in 10 μL 0.1% triﬂuoroacetic acid (TFA, Fluka) to a
concentration of 10 mg/mL at 25±0.5 °C. After 50 min, “fresh
samples” were made by diluting the stock to a ﬁnal concentration of
100 μM in PBS (10 mM NH2PO4, 150 mM NaCl, pH 7.4). Lipids were
purchased from Avanti Polar Lipids (Alabaster, AL). Salts were
generally obtained from Sigma Chemical Co. (St. Louis, MO), with
the exception of KI which was purchased from MP Biomedicals, LLC
(Solon, OH).
2.2. Preparation of liposomes
Solutions of phospholipid in chloroform at desired ratios of
POPC (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine) and
POPG (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-rac-1-glycerol[sodium salt]) were evaporated under a N2 stream and each
sample was dried overnight under vacuum. Lipid ﬁlms were
suspended in 5 mM phosphate–borate–citrate (PBC) buffer, pH 7.4
and vortexed to give multilamellar lipid dispersions. To prepare
large unilamellar vesicles (LUVs), the dispersion was ﬁve times
frozen and thawed in liquid nitrogen and in a 37 °C water bath,
followed by extrusion (15 times) through polycarbonate mem-
branes with 100 nm pores (Avestin, Ottawa, Canada). To prepare
small unilamellar vesicles (SUVs), the dispersion was sonicated in
an ice-water bath using a Branson titanium tip ultrasonicator for
∼1 h at 50% duty cycle until it was transparent. When only a single
lipid was used, the powder was dissolved in buffer directly
followed by the steps described above.
2.3. Fluorescence measurements
Fluorescence studies were carried out using a Fluorolog-3 spectro-
ﬂuorometer (Jobin-Yvon, Edison, NJ). Intrinsic Trp or AMCA ﬂuores-
cence of the peptides was measured before and after addition of
different amounts of phospholipid vesicles to a ﬁxed peptide
concentration. Peptide–lipid interactions were further assessed by
changes in the accessibility of the peptides to aqueous quenchers
(acrylamide and iodide) upon addition of LUVs. Experiments were
carried out by addition of aliquots of concentrated acrylamide or
potassium iodide stock solution to peptide samples in the absence or
presence of LUVs.
2.4. Fourier transform infrared spectroscopy
Polarized ATR-FTIR spectra were recorded on a Vector 22 Fourier
transform infrared spectrometer (Bruker, Billerica, MA). Planar
phospholipid bilayers supported on germanium ATR plates were
prepared by Langmuir–Blodgett deposition and fusion of small
unilamellar vesicles as described previously [30,31]. The substrate-
supported monolayer was 1,2-dimyristoyl-3-sn-phosphatidylcholine
(DMPC), and the monolayer exposed to the buffer compartment was
POPC. Peptides at 20 μM in 5 mM PBC, pH 7.4 were added to the
sample cell, incubated for 5 min at room temperature, and excess
unbound peptide was washed away with 3 volumes of the same
buffer made in D2O (Cambridge Isotope Laboratories, Inc., Andover,
MA, D 99.9%).
2.5. Hydrogen–deuterium exchange (HX)-mass spectrometric
(MS) analysis
The details of HX-MS labeling and HPLC procedures have been
reported previously [29]. Brieﬂy, peptide samples were diluted ten
fold into D2O (Acros Organics, Morris Plains, NJ, D 99.8%) at room
temperature. The labeling solutionwas 90% D (molar) and the pH was
7.0. After proper labeling time, dimethylsulfoxide (DMSO) and
dichloroacetic acid (DCA, Fluka, 95/5 vol/vol) were used as the
dissolution and quench buffers with a ﬁnal pH close to 3.5.
After quenching, the mixture was injected into a 100 μL sample
loop and desalted for ∼1 min through a C8 peptide trap cartridge
(Micro Trap™ 1 mm ID×8 mm, Michrom Bioresources, Inc., Auburn,
CA). Then, the peptide was eluted by a 30%–80% acetonitrile gradient
at a ﬂow rate of 50 μL/min over 2 min and sent directly to the mass
spectrometer. To minimize back-exchange during the analysis, all the
columns, loops, lines and valves were precooled for 1 h and immersed
in ice during all the experiments.
The +1 and +4 charge state peaks were selected for P11-2 and Aβ
analysis respectively. Data were collected in positive ion, zoom scan,
and proﬁle mode on a Thermo Finnigan LTQ linear quadrupole ion trap
mass spectrometer (San Jose, CA) with a standard ESI source. The ESI
voltage was 4.5 kV, capillary temperature 275 °C, sheath gas ﬂow rate
20 U, and tube lens voltage 135 V. The centroidmass for each peakwas
Fig. 1. Effect of the P11-2 on viability of SY5Y cells. Peptide was incubated with cells for
2 h prior to viability measurement using annexin-PE and 7 AAD staining, followed by
ﬂow cytometry. Viability was normalized relative to untreated control cells. The error
bars are the standard error of the mean of replicate samples.
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calculated from Eq. (1).
P = 1− M − M0
N
× 100k ð1Þ
Here, P is the percent of protection. N is the total number of
exchangeable amide backbone protons, 11. M and M0 refer to the
centroid mass for labeled and unlabeled P11-2 peak, respectively.
2.6. Toxicity assay
Viability of cells after 2 h exposure to P11-2 peptides was assessed
using a rapid Annexin-7AAD assay recently reported [32]. In brief, SH-
SY5Y cells were seeded in 96 well plates at a density of 105 cells/well
and allowed to adhere to wells for 24 h in a humidiﬁed 5% CO2/air
incubator at 37 °C. Culture medium was replaced with 100 μL of P11-2
peptide in MEM and cells were incubated with P11-2 peptide for 2 h. To
stain cells, medium was replaced with 100 μL of 1× binding buffer
(0.01 M HEPES/NaOH, pH 7.4, 0.14 M NaCl, 2.5 mM CaCl2). Thereafter,
5 μL of both annexin-phycoerythrin (annexin-PE) (5 ng/well) and 7-
amino-actinomycin D (7AAD) (0.25 μg/well) were added, followed by
10 min incubation in the dark at 25 °C. 150 μL of 2× binding buffer was
then added. 7AAD binds to DNA, and is therefore a measure of
membrane permeability. Annexin-PE binds to phosphatidyl serine,
which accumulates on the membrane at early periods during
apoptosis. Finally, cells were removed from plates by mechanical
scraping, and then analyzed using the BD FACSArray Bioanalyzer ﬂow
cytometer (San Diego, CA). Annexin-PE was excited with the 532 nm
laser and detected using the yellow (564–606 nm) ﬁlter, while 7AAD
was detected using the red (653–669 nm) ﬁlter. Spillover for the two
detectors was calculated using 3 samples one of which was unstained,
another stained with only annexin-PE and the third stained only with
7AAD. To ensure staining, positive controls were prepared by
incubating cells with a 533 μM H2O2 solution in 33% (v/v) MEM in
deionized water. A quadrant gate was used to estimate the percentage
of the total population that was both annexin and 7AAD negative,
taken as the viable population. Relative viability (Vrelative) was
estimated as indicated below where Vtreated is the percentage of
viable cells in the treated population, Vperoxide is the percentage of
viable cells in the peroxide treated population, and Vuntreated is the
percentage of cells in the negative control.
Vrelative =
Vtreated − Vperoxide
Vuntreated − Vperoxide
× 100k ð2Þ
Averages and standard errors of at least ﬁve repeated experiments
are reported for each condition.
3. Results
We set out ﬁrst to demonstrate that the model peptide P11-2
recapitulates some of the biology of Aβ(1–40) and other amyloid
forming peptides, namely that small soluble intermediates are more
toxic than the ﬁnal large ﬁbril-like structures [2–5,21]. The toxicity of
P11-2 to SY5Y cells was measured at three concentrations where the
state of peptide oligomerization is known to differ. At a low concen-
tration of 20 μM, P11-2 does not self-assemble, and remainsmonomeric
[28] with random coil conformation [52,53]. 100 μM is just above the
minimum concentration (70 μM) at which β structures begin to form
and ﬂexible β-sheet ribbons form with width less than 5 nm [28]. As
shown by CD, samples at 100 μM have obvious ordered β-sheet
structure [52,53]. At 300 μM the extent of β-structure is even greater
[52,53], but no rigid ﬁbrils were formed [28].
Fig. 1 shows results of the toxicity assay in which changes in
membrane permeability were detected within 2 h of the addition ofthe peptide [32]. The results demonstrate that the intermediate
oligomers of P11-2 are signiﬁcantly (pb0.01) more toxic than the
monomers and large assemblies at low and high concentrations,
respectively. Therefore, P11-2 toxicity correlates well with the state of
self-assembly as has been described before for Aβ using the same cell
line, assay, and lot of Aβ [32]. It should be noted that the cell viability
reported here is the relative value compared to untreated control cells.
Thus, the 300 μM peptide sample having a higher viability than the
controls resulted in a value over 100%. This suggests that the peptide
may coat the cells, making the membrane less permeable, or the
phosphatidyl serine on the surface less available. The involvement of
membranes in peptide cytotoxicity is consistent with the fact that the
P11-2 peptide has also been shown to display ion conduction across
lipid bilayers [33]. This behavior recapitulates the well-reported
ability of Aβ peptides to form ion channels and change conductance in
planar lipid bilayers [34–38].
Once we had shown that some aspects of Aβ biology were
captured by our model peptide, we sought to utilize P11-2 to examine
features of the peptide–membrane interaction that might be
important in biological function that have been difﬁcult to probe (or
have led to contradictory results) using Aβ [6,12]. Several biophysical
techniques were employed to elucidate the molecular details of the
interaction of P11-2 with lipid liposomes. First, we studied P11-2-
phospholipid interactions by monitoring the changes in tryptophan
(Trp) ﬂuorescence upon the addition of large unilamellar vesicles
(LUVs). The Trp ﬂuorescence intensity decreased with the addition of
either zwitterionic POPC or net negatively charged POPC:POPG (2:1
mol ratio) liposomes to the peptide. Fig. 2 shows the corresponding
titration curves obtained with 20 μM P11-2. Although the ﬂuorescence
intensity decreased with liposome concentration, the wavelength of
the maximum intensity was neither blue nor red shifted without
signiﬁcant variation beyond the measurement error of ±1 nm (Figure
S2, Supplementary Information). Light scattering attenuation from the
liposomes was also tested by addition of liposomes to solutions of the
ﬂuorophore AMCA and found to be negligible (data not shown)
compared to the drops in Fig. 2. The binding isotherm data in Fig. 2
were ﬁt with a partition equilibriummodel [39–41] to obtain peptide–
lipid partition constants (Kapp, M−1). The partition constants
(averaged from 5 independent experiments) were (3.7±0.2)×103
M−1 for POPC and (4.2±0.3)×103 M−1 for POPC:POPG (2:1). These
constants are apparent because no attempt was made to correct for
electrostatic double layer effects at the membrane surface.
Fig. 2. The relative ﬂuorescence of P11-2 at 20 μM in 5 mM PBC, pH 7.4 is shown as
function of lipid concentration. Binding of P11-2 to liposomes composed of POPC (●) and
POPC/POPG (2:1) (▪). The curve represents a ﬁt of a partition binding model [41].
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acrylamide to the P11-2 tryptophan residue yielded information
about the mode of peptide insertion in the model membranes
(Fig. 3A). Fluorescence intensity was measured as a function of
quencher concentration in the outer aqueous phase of phospholipid
vesicles [42]. The order of the ﬂuorescence quenching was
(solution)N(POPC)≈(POPC/POPG) showing that P11-2 is buried to
approximately the same extent in both model membranes. Due to the
incidence of static quenching at higher acrylamide concentrations
[43], the Stern–Volmer constants (KSV) were calculated from the plots
between 0 and 0.1 M acrylamide. The measured ﬂuorescence values
were corrected for absorption of acrylamide at the absorption
wavelength of Trp as we have previously [56]. KSV values for P11-2
were 44, 31 and 29 M−1 in the absence of lipid, presence of POPC, and
presence of POPC/POPG liposomes, respectively. The same general
trends were observed with another soluble quencher of Trp
ﬂuorescence, iodide (Fig. 3B) with and without POPG liposomes.
The KSV values dropped from 10.6 M−1 to 6.5 M−1 in presence of the
POPG liposomes. The ratio of KI quenching KSV values in absence andFig. 3. Stern–Volmer plot for the quenching of P11-2 ﬂuorescence by acrylamide (A) and
KI (B) in aqueous buffer (▪), and bound to liposomes composed of POPC (●) and POPC/
POPG (2:1) in panel A or POPG in panel B (▴). The curve represents a ﬁt of the data
points using the method previously described [42].presence of the liposomes (1.6) is in good agreement with the ratio
obtained using acrylamide (1.4; Fig. 3A) with POPC liposomes. The
depletion of iodide in the vicinity of themembrane surfacemeans that
measured KSV values should be considered upper limits.
Because Aβ lacks a Trp reporter residue, similar experiments were
performed using Aβ labeled with the ﬂuorophore, AMCA. EM showed
that concentrated, 100 μM stock solutions of AMCA-Aβ were mostly
devoid of any large aggregates, although smaller amorphous struc-
tures (10–15 nm) were observed (See Supplementary Information). A
similar study with Aβ(1–40) labeled with a 7-diethylamino-cou-
marin-3-carbonyl (DAC) group at the N-terminus (DAC-Aβ) reported
little change in aggregation behavior [55].
Experiments with freshly dissolved AMCA-labeled Aβ(1–40) at
10 μM exhibited a very similar behavior to P11-2. The AMCA
ﬂuorescence decreased upon Aβ binding to negatively charged
liposomes and the liposomes offered protection against the quencher
iodide when compared with the quenching of the peptide in the
absence of vesicles (Fig. 4). KSV values for Aβ were 74 and 32 M−1 in
absence and presence of POPG liposomes, respectively. Also support-
ing the solvent exposed nature of fresh AMCA-Aβ, experiments with
aged showed lower KSV values than freshly prepared Aβ (See
Supplementary Information).
Monitoring peptide aggregation in solution and in the presence of
liposomes is important to understand aspects of their molecular
interactions, in particular with regard to pore formation. The use of
hydrogen–deuterium exchange coupled with electrospray ionization
mass spectrometry has proven to be a versatile technique to study
different aggregation states of Aβ peptides [44]. HX/MS has been used
to study structural aspects and the kinetics of Aβ peptide aggregation
[7,45]. In order to further test whether P11-2 can be a good model for
Aβ aggregation, we examined the protection from deuterium
exchange of P11-2 at 20 μM where it is not likely to self-associate and
at higher concentrations where it likely forms oligomers. Fig. 5 shows
that monomeric P11-2 gains almost as much deuterium as fully labeled
P11-2 (Fig. 5B), while 250 μM peptide (Fig. 5C) that adopts an
oligomeric state protects∼5 of its exchangeable amide hydrogens. The
protection percentages for 20 μM and 250 μM samples were 3% and
47%, respectively. This result demonstrates that P11-2 possesses a core
that is resistant to deuterium exchange, recapitulating another
important feature of the structural behavior of Aβ [29].
HX-MS experiments were also carried out for P11-2 at low
concentration (20 μM) and compared with fresh samples of Aβ(1–Fig. 4. Stern–Volmer plot for the quenching of Aβ(1–40) ﬂuorescence by KI in aqueous
buffer solution (▪) and in presence of liposomes composed of POPG (●). The curve
represents a ﬁt of the data points as in Fig. 3.
Fig. 7. Representative mass spectra of freshly prepared Aβ(1–40) at 100 μM in the (B)
Fig. 5. Hydrogen–deuterium exchange of P11-2 in solution: (A) 20 μM P11-2; solid line,
unlabeled control; dashed line, fully labeled control. (B) P11-2 labeled at 20 μM for 10 s.
(C) P11-2 at 250 μM labeled for 10 s.
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a function of increasing lipid concentration. Similar results were
obtained with fresh preparations of the Aβ peptide in absence
(Fig. 7B) and presence (Fig. 7C) of the same negatively charged
liposomes. In the absence of liposomes (Fig. 7B) a fully solvent
exposed species is accompanied by a protected species that we have
observed previously and shown by SEC under identical conditions toFig. 6. Representative mass spectra of P11-2 at 20 μM bound to POPG liposomes at
different lipid concentrations: (A) 0.005 mM; (B) 0.513 mM; (C) 1.19 mM. The
corresponding mass spectrum in the absence of POPG is shown in Fig. 5B.
absence and (C) presence of 1.19 mM POPG liposomes and incubated for 30 min.
Deuterium labeling time was 10 s. In Panel A, mass spectra for unlabeled Aβ(1–40)
(solid line) and a fully labeled Aβ(1–40) (dashed line) in solution are shown for
comparison. All spectra are normalized to their maximum signal intensity.be a mixture of monomer and dimer [7,29]. Murphy and colleagues
have also reported equilibrium mixtures of monomer and dimer at
similar peptide concentrations [54]. While the quantitative distribu-
tions differ, the addition of lipid model membranes increased the
fractions of both the Aβ and P11-2 peptides that remained resistant to
deuterium exchange. This indicates that P11-2 models the behavior of
Aβ quite well with regard to self-association at membrane surfaces.
P11-2 is known to form ion pores in lipid bilayers [33], which
suggests that the peptide undergoes a conformational change on lipid
binding. In order to more directly explore the conformation of P11-2
bound to liposomes, we examined the peptide bound to supported
bilayers by ATR-FTIR spectroscopy. Representative polarized FTIR
spectra of 20 μMP11-2 bound to POPC bilayers are shown in Fig. 8A. The
amide I′ band at 1600–1700 cm−1 is sensitive to the conformation of
the peptide. Bands at 1625–1640 cm−1 are related to peptides
adopting a β-sheet conformation, and bands at 1640–1650 cm−1 are
related to deuterated irregular (random coil) secondary structures
[30]. The higher intensity band at around 1730 cm−1 arises from the
lipid ester carbonyl stretch vibration. The intensities of component
bands were estimated from Gaussian curve ﬁtting and indicated a β-
sheet fraction of 10–20% and 80–90% irregular structures. For P11-2 in
the absence of liposomes, ATR-FTIR is too insensitive to assess
secondary structure; however CDmeasurements showed no evidence
of any β structure (Fig. 8B). In addition, by using the online CD spectra
deconvolutor (SOMCD http://geneura.ugr.es/cgi-bin/somcd/index.
cgi), random coil was determined to be themajor secondary structure,
96%, with β-sheet only 2% and turns and helix making up the
remaining 2%. Negligible β structure is also consistent with previous
solution measurements in the same concentration range [52,53]. It is
challenging to be quantitative comparing small amounts of β structure
Fig. 8. Secondary structure of P11-2 in presence and absence of liposomes. (A) Polarized
ATR-FTIR spectra of P11-2 at 20 μMbound to planar lipid bilayers composed of POPCwith
the polarizers oriented at 0°from the plane of the ATR plate and membrane. (B) CD
spectra of P11-2 at 20 μM without liposomes.
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sheet in the presence of liposomes.
4. Discussion
In this work we employed several biophysical techniques to
examine the interactions of the rationally designed peptide P11-2 with
lipid model membranes. These were compared with similar studies of
the Aβ(1–40) peptide, and the results showed that P11-2 recapitulates
several structural and functional features exhibited by Aβ(1–40).
Binding studies employing ﬂuorescent spectroscopy showed that the
peptide P11-2 binds to both zwitterionic and negatively charged
membrane interfaces with a slight preference for the latter. The
similar binding of P11-2 to both zwitterionic and anionic liposomes
indicates that hydrophobic interactions dominate the binding. How-
ever, the slight preference for negatively charged liposomes shows
that electrostatic interactions also contribute in aminor fashion to this
process. The present results showing the binding of P11-2 with
zwitterionic and negatively charged lipid agrees with several previous
studies that showed that Aβ peptides bind both types of model
membranes [12–18]. The similar binding behavior of the P11-2 and
Aβ(1–40) is consistent with their equivalent average hydrophilicity
(−0.1) by the scale of Hopp and Woods [57] and their relatively low
overall net charge (0 and −3, respectively) at pH 7.4.
The insertion of a Trp residue into a more hydrophobic environ-
ment is usually characterized by a ﬂuorescence blue shift and by an
increase in the ﬂuorescence quantum yield. In certain cases such as
with penetratin or TAT-PTD peptide [41,46], Trp ﬂuorescence
decreased while still exhibiting a blue shift. Here, though the
ﬂuorescence intensity decreased with liposome concentration, the
wavelength of the maximum intensity was neither blue nor red
shifted, but did not vary signiﬁcantly beyond the measurement error
of ±1 nm (Figure S2, Supplementary Information). This unusual
intensity decrease could be due to conformational changes and/or
self-association upon binding to liposomes. In particular, in-register
self-association expected for P11-2 [25] could lead to self quenching of
Trp residues. Such in-register structures are well established for Aβ
ﬁbrils [47]. Special interactions with phospholipid headgroups and/or
π-cation interactions between the Trp indole moiety and arginine in
the peptide might also account for a reduction in Trp ﬂuorescence[41,48]. Fluorescence quenching by acrylamide and iodide of the lipid-
free and lipid-bound peptides showed that the presence of liposomes
offers protection against quenching for Trps of P11-2 and AMCA
attached to Aβ. The protection might come from the insertion of the
probes into the liposome surface, but also may come from the
accelerated aggregation induced self quenching.
It is useful to compare the KSV values to those of other membrane
disrupting peptides, such as mellitin. Because the KSV values regressed
here were not strictly corrected for inner ﬁlter effects, it is perhaps
most appropriate to compare the ratio of KSV values in the absence vs.
presence of the liposome, R. This ratio might reﬂect the strength of the
peptide–lipid binding interaction. For P11-2, the values of R for the
quenching in presence of POPC, POPC/POPG and POPG are 1.4, 1.5 and
1.6. For AMCA-Aβ, the R in presence of POPG is 2.3. In comparison for
mellitin, the R in presence and absence of egg PC is 5.8 [55]. Thus,
above results suggest that though Aβ and P11-2 do interact with the
lipids, their interactions are weaker than those of mellitin.
The binding of Aβ peptides to lipidmodel membranes is a ﬁrst step
towards their established ability to form ion channels and change the
conductance and dielectric properties in planar lipid bilayers
[34–38,49–50]. In addition to the binding of P11-2 to lipid bilayers
and liposomes that has been demonstrated in this work, P11-2 has been
previously shown to also form pores and to display ion channel-like
activity in planar lipid bilayers [33]. Our HX-MS studies show that both
P11-2 and Aβ(1–40) self-associate into larger aggregates under certain
conditions and that these aggregates are protected from the
deuterium–hydrogen exchange in lipid environments, probably by
membrane-mediated self-association. It is also interesting to notice
that there is overlap in degree of HX protection between the
aggregates of P11-2 in solution and the peptide contacted with
liposomes. The HX-MS signal intensity for the former ranges from
1592.5 to 1605 m/z (Fig. 5C) and the latter from 1592.5 to 1600 (Fig.
6C). This overlap in protection might support the idea that the two
aggregates may be related in structure. However, the wider, asym-
metric labeling distribution exhibited by aggregates in solution
suggests the presence of a wider distribution of structures, probably
including those with similar solvent accessibility as the more
protected population produced by the liposomes. These results are
in agreement with and further generalize the ﬂuorescence quenching
results to include the labile protons in the P11-2 and Aβ structures.
Therefore, P11-2 appears to recapitulate lipid binding, self-assembly,
and pore formation of Aβ peptides in lipid model membranes.
P11-2 at 20 μM in aqueous solution is below the critical association
concentration of 45 μM and therefore occurs in a monomeric random
coil conformation at this concentration. However, when P11-2 binds to
lipid bilayers, our ATR-FTIR spectroscopic studies show that some β-
structure is induced. This indicates that the lipid bilayer promotes a
conformational change and possibly self-association into larger β-
sheet aggregates. Again, similar results were obtained with Aβ(1–40)
[13,18,51]. Our HX-MS observations also show an increase in the
amount of the protected, presumably self-associated, state in the
presence of lipid for both P11-2 and Aβ(1–40). This lipid-induced β-
sheet formation is likely driven by hydrogen-bond formation between
neighboring peptide strands in membrane interfaces that, if unsa-
tisﬁed, would energetically be very unfavorable [52,53]. Forming
higher oligomer β-sheets inmembranesmay be a prerequisite for P11-2
to form ion-conducting pores in lipid bilayers. The membrane-
induced oligomeric β-structures of P11-2 may also be responsible for
cell toxicity that we determined in this work to be depended on the
state of self-assembly, very similar to what has been previously
observed with Aβ.
In conclusion, the present work represents the ﬁrst systematic
study of the interaction of the P11-2 model peptide with lipid model
membranes. The results reveal that this model peptide recapitulates
several key features of the Aβ amyloid peptide. Why might one want
to study such a model peptide rather than Aβ itself? The main reason
1720 L.C. Salay et al. / Biochimica et Biophysica Acta 1788 (2009) 1714–1721is an attempt to isolate general from sequence-speciﬁc mechanisms
that have been implicated in Aβ toxicity. With regard to membranes
alone, Aβ has been reported to bind and increase self-association on
membranes [12,16,18], to form ion channels [34–37], and to increase
membrane conductance [38,49–50]. Oxidatively damaged lipids have
also been purported to stimulate formation of ﬁbrils [51]. While the
neurotoxicity of Aβ(1–40) probably involves multiple mechanisms, it
is important to know which of these are sequence-speciﬁc and which
are general. Dissecting the nature and dominance of these diverse
mechanisms can be difﬁcult with competing effects and the complex
behavior of Aβ. The relatively well-behaved model peptide P11-2 and
its validation in the present work should facilitate future investiga-
tions of some aspects of the toxicity of amyloid peptides, namely those
that are general and less dependent on peptide sequence. In particular,
well deﬁned changes in sequence which alter oligomer size via the
rules suggested by solution phase studies of these rationally designed
peptides [27,33] could enable investigation of oligomer size on
membrane permeability and neurotoxicity. Alternatively, changes in
sequence that modulate membrane binding afﬁnity would facilitate
the effect of such changes on membrane-induced oligomerization,
permeability and toxicity. Such studies will help us better understand
the intrinsic ability of proteins and peptides to self-assemble at
membrane surfaces and how such self-assembly may lead to
pathological situations in amyloid diseases.
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